Candel Therapeutics, Inc.
CADL • NASDAQ
Candel Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Paul-Peter Tak, with a market cap of $352.3M.
CEOPaul-Peter Tak
Next Earnings
Upcoming earnings announcement for Candel Therapeutics, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.30
Earnings History
Past 12 earnings reports for Candel Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | -$0.54Est: -$0.24 | -125.0% | - | — |  10-K |
| Nov 13, 2025 | Q3 2025 | -$0.21Est: -$0.17 | -23.5% | - | — | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.09Est: -$0.17 | +47.1% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | $0.13Est: -$0.24 | +154.2% | - | — | 10-Q |
| Mar 13, 2025 | Q4 2024 | -$0.40 | — | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.33 | — | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.74 | — | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.28 | — | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.38Est: -$0.16 | -137.5% | -Est: $10.0K | -100.0% | 10-K/A |
| Nov 9, 2023 | Q3 2023 | -$0.29Est: -$0.19 | -52.6% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.33Est: -$0.30 | -10.0% | - | — | — |
| May 11, 2023 | Q1 2023 | -$0.30Est: -$0.35 | +14.3% | - | — | — |